Stocks › BDX
BECTON DICKINSON & CO
BDX·NYSE·
United States·USD
$212.78
+0.10 (+0.05%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
BDX
BECTON DICKINSON & CO · NYSE
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
BDXS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of BDX by members of U.S. Congress · 173 on record · 15 in the last 12 months
Whale Activity
Position changes in BDX reported for 2026-09-30 by 1593 institutional filers
- Increased484
- New163
- Held210
- Decreased575
- Closed89
- No prior filing72
| Filer | Shares | Value | Change |
|---|---|---|---|
| BlackRock, Inc. | 23.6M | $4.23B | decreased |
| VANGUARD CAPITAL MANAGEMENT LLC | 17.8M | $3.19B | decreased |
| STATE STREET CORP | 15.2M | $2.72B | increased |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 14.7M | $2.63B | decreased |
| First Eagle Investment Management, LLC | 13.9M | $2.49B | increased |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 7.8M | $2.39B | decreased |
| FRANKLIN TEMPLETON INC | 7.7M | $1.60B | increased |
| Invesco Ltd. | 8.9M | $1.59B | decreased |
| GEODE CAPITAL MANAGEMENT, LLC | 8.1M | $1.44B | decreased |
| GREENHAVEN ASSOCIATES INC | 5.9M | $1.06B | increased |
| WELLINGTON MANAGEMENT GROUP LLP | 5.6M | $999.4M | decreased |
| PRICE T ROWE ASSOCIATES INC /MD/ | 4.1M | $727.0M | increased |
Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.
Insider Trading
Net shares bought (+) or sold (−) on the open market by BDX insiders, by quarter · Form 4
Recent Insider Transactions
2,127 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Polen Thomas E JrChairman, CEO and President · Director | Sale | −2,993 | $210.00 | $629K | Nov 5, 2026 | Form 4 ↗ |
| Feld MichaelEVP, Chief Revenue Officer | Sale | −76 | $198.13 | $15K | Oct 26, 2026 | Form 4 ↗ |
| Feld MichaelEVP, Chief Revenue Officer | Sale | −76 | $183.70 | $14K | Sep 28, 2026 | Form 4 ↗ |
| Roque VitorEVP & Chief Financial Officer | Tax withholding | −190 | $0.00 | $0 | Sep 2, 2026 | Form 4 ↗ |
| Feld MichaelEVP, Chief Revenue Officer | Sale | −165 | $188.49 | $31K | Aug 26, 2026 | Form 4 ↗ |
| Feld MichaelEVP, Chief Revenue Officer | Tax withholding | −1,049 | $0.00 | $0 | Aug 20, 2026 | Form 4 ↗ |
| Polen Thomas E JrChairman, CEO and President · Director | Sale | −4,152 | $185.00 | $768K | Aug 13, 2026 | Form 4 ↗ |
| Polen Thomas E JrChairman, CEO and President · Director | Disposition to issuer | −39.1K | $185.00 | $7.2M | Aug 13, 2026 | Form 4 ↗ |
| Polen Thomas E JrChairman, CEO and President · Director | Option exercise | +43.3K | $167.25 | $7.2M | Aug 13, 2026 | Form 4 ↗ |
| Goette RolandEVP and President, EMEA | Sale | −2,438 | $180.84 | $441K | Aug 11, 2026 | Form 4 ↗ |
| Feld MichaelEVP, Chief Revenue Officer | Sale | −75 | $157.13 | $12K | Jul 27, 2026 | Form 4 ↗ |
| Muhsin BilalEVP & President Connected Care | Tax withholding | −1,935 | $0.00 | $0 | Jul 2, 2026 | Form 4 ↗ |
| Muhsin BilalEVP & President Connected Care | Grant / award | +14.3K | $0.00 | $0 | Jul 1, 2026 | Form 4 ↗ |
| Feld MichaelEVP, Chief Revenue Officer | Sale | −75 | $152.80 | $11K | Jun 26, 2026 | Form 4 ↗ |
| Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm | Sale | −1,100 | $145.66 | $160K | Jun 24, 2026 | Form 4 ↗ |
| Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm | Sale | −1,100 | $151.48 | $167K | Jun 10, 2026 | Form 4 ↗ |
| Polen Thomas E JrChairman, CEO and President · Director | Sale | −2,764 | $146.35 | $405K | Jun 1, 2026 | Form 4 ↗ |
| Polen Thomas E JrChairman, CEO and President · Director | Disposition to issuer | −17.4K | $146.15 | $2.5M | Jun 1, 2026 | Form 4 ↗ |
| Polen Thomas E JrChairman, CEO and President · Director | Option exercise | +20.2K | $126.16 | $2.5M | Jun 1, 2026 | Form 4 ↗ |
| Menziuso PeterEVP and President, BDI | Grant / award | +14.3K | $0.00 | $0 | Jun 1, 2026 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding BDX · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| First Eagle Global Fund First Eagle Funds | 9.2M | $1.52B | 1.99% | Jul 31, 2026 |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 8.7M | $1.32B | 0.06% | Jun 30, 2026 |
| VANGUARD 500 INDEX FUND VANGUARD INDEX FUNDS | 7.1M | $1.08B | 0.06% | Jun 30, 2026 |
| VANGUARD MID-CAP INDEX FUND VANGUARD INDEX FUNDS | 6.0M | $903.5M | 0.40% | Jun 30, 2026 |
| Fidelity 500 Index Fund Fidelity Concord Street Trust | 3.6M | $672.8M | 0.08% | Aug 31, 2026 |
| iShares Core S&P 500 ETF iShares Trust | 3.8M | $573.5M | 0.06% | Jun 30, 2026 |
| Putnam Large Cap Value Fund | 3.1M | $507.5M | 0.92% | Jul 31, 2026 |
| State Street(R) SPDR(R) S&P 500(R) ETF Trust | 3.3M | $505.4M | 0.06% | Jun 30, 2026 |
| VANGUARD EQUITY INCOME FUND VANGUARD FENWAY FUNDS | 2.9M | $439.1M | 0.67% | Jun 30, 2026 |
| VANGUARD VALUE INDEX FUND VANGUARD INDEX FUNDS | 2.6M | $396.6M | 0.16% | Jun 30, 2026 |
Mutual funds and ETFs whose N-PORT filings list BDX's shares (CUSIP 075887109), each fund at its latest report since Apr 22, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming becton dickinson as client
- BECTON, DICKINSON AND COMPANYBECTON DICKINSON AND COMPANY · 2026 Q1 · TAX, BUD, TRD, MMM$780K
Filing ↗ - BECTON, DICKINSON AND COMPANYBECTON DICKINSON AND COMPANY · 2026 Q3 · HCR, TAX, BUD, TRD$390K
Filing ↗ - BGR GOVERNMENT AFFAIRSBECTON, DICKINSON AND COMPANY · 2026 Q3 · TAR$80K
Filing ↗ - BROWNSTEIN HYATT FARBER SCHRECK, LLPBECTON, DICKINSON AND COMPANY · 2026 Q3 · HCR, MMM, IMM, TRD$50K
Filing ↗ - DCI GROUP, L.L.C.BECTON, DICKINSON AND COMPANY · 2026 Q3 · TAR$60K
Filing ↗
Government Contracts
Federal awards to becton dickinson · USAspending
$28.8MAwarded · 262 contracts on record
- Department of Veterans AffairsMEDICAL LAB SUPPLIES$79K
Oct 1, 2019 · ↗ - Department of Health and Human ServicesNHGRI: SERVICE FOR SC PRIORITY FACSARIA FUSION SORP. SERIAL NUMBER: R65828200090. PERIOD OF PERFORMANCE 12/01/2026 TO 11/30/2027. SEVERABL$51K
Dec 1, 2026 · ↗ - Department of AgricultureFACSDISCOVER S8 CELL SORTER WITH CELLVIEW IMAGE TECHNOLOGY$305K
Jul 29, 2026 · ↗ - Department of Defense4553440177!SET IV ADMINISTRATION 20GTT 104INL VENTE$585
May 6, 2021 · ↗ - Department of Health and Human ServicesAMBIS # 1935825 MAINTENANCE FACSARIA FUSION$26K
Dec 4, 2018 · ↗ - Department of Health and Human ServicesSERVICE AGREEMENT$16K
Nov 10, 2021 · ↗ - Department of Health and Human ServicesBECTON, DICKINSON AND COMPANY:1106636 [23-010951]$18K
Aug 30, 2023 · ↗ - Department of Health and Human ServicesIN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$389K
Sep 8, 2015 · ↗
U.S. Patents
Recent USPTO applications naming BECTON DICKINSON & CO
No USPTO patent applications found for BECTON DICKINSON & CO.
Annual Financials
From BDX's 10-K filings · XBRL
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $21.84B | $20.18B | $19.37B | $18.87B | $19.13B |
| Operating income | $2.58B | $2.40B | $2.11B | $2.28B | $2.25B |
| Net income | $1.68B | $1.71B | $1.48B | $1.78B | $2.09B |
| Diluted EPS | $5.82 | $5.86 | $4.94 | $5.88 | $6.85 |
| Operating cash flow | n/a | n/a | n/a | n/a | $4.65B |
| Cash and equivalents | $641.0M | $1.72B | $1.42B | $1.01B | $2.28B |
| Total assets | $55.33B | $57.29B | $52.78B | $52.93B | $53.87B |
| Shareholders' equity | $25.39B | $25.89B | $25.80B | $25.28B | $23.68B |
As BECTON DICKINSON & CO tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Nov 25, 2025 ↗
Stock Splits
Every split and reverse split in the price history
- 14-for-11Stock splitFeb 10, 2026
- 38-for-37Stock splitApr 1, 2022
- 2-for-1Stock splitAug 21, 1998
- 2-for-1Stock splitAug 16, 1996
- 2-for-1Stock splitMar 1, 1993
- 2-for-1Stock splitMar 3, 1986
Split dates and ratios from the price history · Close Prices from Tiingo.com
Material Events (8-K)
Corporate events filed with the SEC
- 8-K · Items 2.02, 9.01Results of operationsNov 5, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsAug 6, 2026
EDGAR ↗ - 8-K · Items 5.02, 7.01, 9.01Officer / director change · Reg FD disclosureJul 22, 2026
EDGAR ↗ - 8-K · Items 7.01Reg FD disclosureMay 29, 2026
EDGAR ↗ - 8-K · Items 1.01, 2.03, 9.01Material agreement · Direct financial obligationMay 20, 2026
EDGAR ↗ - 8-K · Items 8.01, 9.01Other eventsMay 12, 2026
EDGAR ↗ - 8-K/A · Items 5.02, 7.01, 9.01Officer / director change · Reg FD disclosureMay 7, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsMay 7, 2026
EDGAR ↗
About BECTON DICKINSON & CO
From SEC EDGAR company records
Industry (SIC 3841)Surgical & Medical Instruments & Apparatus
SectorHealthcare
HeadquartersFRANKLIN LAKES, NJ
IncorporatedNJ
SEC CIK0000010795 ↗






